Why Generic Drug Makers May Benefit from 505(b)(2) Approval
A few years ago, there was much talk of the “patent cliff” facing blockbuster drugs like Lipitor and other huge name-brand drugs. The “patent cliff” may have spelled the end…
The post Why Generic Drug Makers May Benefit from 505(b)(2) Approval appeared…
